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Força dos músculos respiratórios em crianças e adolescentes com asma: 
similar à de indivíduos saudáveis?
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Abstract
Objective: To compare children/adolescents with mild or moderate asthma and healthy subjects in terms of 
respiratory muscle strength, correlating it with spirometric variables in the former group. Methods: This was a 
cross-sectional study involving individuals 6-16 years of age and clinically diagnosed with mild/moderate asthma, 
together with a group of healthy, age- and gender-matched subjects. We determined spirometric values, as well 
as MIP and MEP, and we selected three reproducible measurements (variation < 10%). Results: We evaluated 
75 patients with asthma and 90 controls. The mean age was 10.0 ± 2.6 years. There were no statistically 
significant differences between the controls and the asthma group regarding MIP (−89.7 ± 26.7 cmH2O vs. 
−92.2 ± 26.3 cmH2O; p = 0.541) or MEP (79.2 ± 22.9 cmH2O vs. 86.4 ± 24.0 cmH2O; p = 0.256). The groups 
were subdivided by age (children and adolescents: 6-12 and 13-16 years of age, respectively). Within the 
asthma group, there was a significant difference between the child and adolescent subgroups in terms of MEP 
(74.1 ± 24.1 cmH2O vs. 92.1 ± 21.9 cmH2O; p < 0.001) but not MIP (p = 0.285). Within the control group, there 
were significant differences between the child and adolescent subgroups in terms of MIP (−79.1 ± 17.7 cmH2O 
vs. −100.9 ± 28.1 cmH2O; p < 0.001) and MEP (73.9 ± 18.7 cmH2O vs. 90.9 ± 28.1cmH2O; p < 0.001). In the 
asthma group, spirometric variables did not correlate with MIP or MEP. Conclusions: In our sample, asthma 
was found to have no significant effect on respiratory muscle strength.
Keywords: Asthma; Respiratory muscles; Respiratory function tests.
Resumo
Objetivo: Comparar a força dos músculos respiratórios de crianças e adolescentes com asma leve/moderada com 
a de indivíduos saudáveis e correlacionar variáveis da espirometria com a força desses músculos nos indivíduos 
com asma. Métodos: Estudo transversal com indivíduos (6-16 anos de idade) com diagnóstico clínico de asma 
leve/moderada e voluntários saudáveis pareados por idade e gênero. Foram determinados valores espirométricos, 
PImáx e PEmáx, sendo selecionadas três medidas reprodutíveis (variação < 10%). Resultados: Foram avaliados 
75 pacientes com asma e 90 controles. A média de idade foi de 10,0 ± 2,6 anos. Não houve diferenças 
estatisticamente significantes entre o grupos controle e asma em relação a PImáx (−89,7 ± 26,7 cmH2O vs. 
−92,2 ± 26,3 cmH2O; p = 0,541) e PEmáx (79,2 ± 22,9 cmH2O vs. 86,4 ± 24,0 cmH2O; p = 0,256). Os dois grupos 
foram subdivididos em crianças (6-12 anos) e adolescentes (13-16 anos). Nos subgrupos de crianças e adolescentes 
no grupo asma, houve diferença da PEmáx (74,1 ± 24,1 cmH2O vs. 92,1 ± 21,9 cmH2O; p < 0,001), mas não 
da PImáx (p = 0,285). Nos subgrupos de crianças e adolescentes no grupo controle, houve diferenças de PImáx 
(−79,1 ± 17,7 cmH2O vs. −100,9 ± 28,1 cmH2O; p < 0,001) e PEmáx (73,9 ± 18,7 cmH2O vs. 90,9 ± 28,1 cmH2O; 
p < 0,001). Não houve correlação das variáveis de espirometria com PImáx e PEmáx nos pacientes do grupo 
asma. Conclusões: Na presente amostra, a presença de asma não determinou alterações significativas na força 
dos músculos respiratórios.
Descritores: Asma; Músculos respiratórios; Testes de função respiratória.
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Methods
This was a cross-sectional study of a probability 
sample of children and adolescents aged 6-16 
years living in the city of Maceió, Brazil, and 
treated at the Asthma Program Outpatient Clinic, 
located in the same city. The study was approved 
by the Research Ethics Committee of the Federal 
University of São Paulo, located in the city of São 
Paulo, Brazil. The parents or legal guardians of 
all participants gave written informed consent.
Two groups were formed, namely asthma 
and control. The patients in the asthma group 
had been clinically diagnosed with asthma at 
least six months prior, in accordance with the 
Global Initiative for Asthma criteria.(22) All of 
them were classified as having mild or moderate 
persistent asthma after having been evaluated by 
a specialist. The individuals in the control group 
were matched for age and gender with those 
in the asthma group and were recruited from 
two primary health care clinics of the municipal 
health system during routine visits or visits for 
immunization.
The exclusion criteria for the two groups were 
as follows: being under treatment with systemic 
corticosteroids; having undergone thoracic surgery; 
having been diagnosed with heart disease or 
neuromuscular disease; having had upper or 
lower airway infection in the two weeks preceding 
the tests; receiving respiratory therapy or any 
physical training more than twice a week; being 
unable to perform the pulmonary function test 
in accordance with the recommendations(23); and 
having nutritional disorders.(24)
The study participants in the asthma and 
control groups were subdivided by age into 
children (6-12 years of age) and adolescents 
(13-16 years of age) in order to determine the 
influence of age (Figure 1).
After admission, each individual was evaluated 
at a single time point, always in the afternoon. 
They underwent anthropometric measurement, 
spirometry, and assessment of respiratory 
Introduction
Asthma is the most common chronic lung 
disease in children,(1-4) being characterized by 
increased airway resistance and air trapping due 
to reduced expiratory flow. These two factors 
lead to lung hyperinflation, changing respiratory 
mechanics and, consequently, impairing kinetics 
in respiratory muscles.(5)
In patients with obstructive pulmonary disease, 
the respiratory muscles, especially the inspiratory 
muscles, are shortened, and this compromises their 
capacity to generate force.(6-8) However, because 
the respiratory muscles are often subjected to 
high loads, they might undergo adaptations, 
including hypertrophy.(9) This mechanism can act 
as involuntary muscle training, possibly leading 
to an increase in strength.(10,11) Previous studies 
have shown that this overload causes an increase 
in oxidative, fatigue-resistant muscle fibers, as 
well as an increase in the respective myosin 
molecules, a reduction in sarcomere length, 
an increase in mitochondrial density, and an 
increase in capillary density in the diaphragm 
and intercostal muscles.(12,13)
Respiratory muscle strength can be measured 
noninvasively by determining maximal respiratory 
pressures with a manometer.(14) These pressures 
reflect not only the strength of respiratory muscle 
contraction but also the elastic recoil of the 
chest wall and lungs. While MIP measures the 
strength of inspiratory muscle contraction, MEP 
measures expiratory muscle strength.(15,16)
Previous studies have shown that the variation 
of MIP among individuals reflects the variation 
of the structural attributes of the inspiratory 
muscles, in particular the muscular cross-sectional 
area of the diaphragm,(17-19) and that adults with 
asthma have reductions of up to 30% in maximal 
respiratory pressures as a result of the effects 
of hyperinflation.(20) Measurement of maximal 
respiratory pressures is very well known and 
also widely used to assess children with chronic 
lung disease; however, there are questions about 
the value of respiratory muscle strength in this 
group of patients.(21)
The objective of the present study was to 
compare children/adolescents with mild or 
moderate asthma and healthy controls in terms 
of respiratory muscle strength—as determined by 
measuring maximal respiratory pressures—and 
correlate MIP and MEP with spirometric variables 
in the former group. Figure 1 - Groups studied.
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5%. Therefore, it was estimated that 70 children 
were required in each group.
Sample homogeneity was confirmed by the 
Kolmogorov-Smirnov test, and parametric tests 
were used to compare variables between the 
groups. Data are expressed as mean and standard 
deviation.
The primary variables were MIP and MEP, 
which were compared between the two groups, 
and the secondary variables were age, gender, 
and spirometric variables.
The unpaired Student’s t-test was used for 
the comparison of MIP and MEP between the 
asthma and control groups, as well as between 
their subgroups (children and adolescents). The 
same was done for the comparison of FVC, FEV1, 
FEV1/FVC, and age between the groups.
In order to determine the correlation between 
respiratory muscle strength variables (i.e., MIP 
and MEP) and spirometric variables (i.e., FEV1, 
FVC, and FEV1/FVC) in the asthma group, we 
calculated Pearson’s correlation coefficient.
For all tests, the level of significance required 
to reject the null hypothesis was set at 5%.
Results
We evaluated 217 children and adolescents; 
of those, 165 were included in the study: 75 
patients with asthma and 90 controls (Figure 1). 
There were 41 males (54%) in the asthma group 
and 43 males (47%) in the control group. Table 1 
shows some characteristics of the population 
studied.
There were no statistically significant 
differences between the control group and the 
asthma group regarding MIP (−89.7 ± 26.7 cmH2O 
vs. −92.2 ± 26.3 cmH2O; Figure 2A) or MEP 
(79.2 ± 22.9 cmH2O vs. 86.4 ± 24.0 cmH2O; 
Figure 2B).
There were no differences in MIP or MEP 
between males and females in the control group 
or in the asthma group (p > 0.05).
The groups were subdivided by age (children 
and adolescents). The asthma group comprised 
36 children and 39 adolescents, and the control 
group comprised 46 children and 44 adolescents.
In the control group, MIP and MEP were 
higher in the adolescents than in the children 
(p < 0.001).
In the asthma group, only MEP was higher in 
the adolescents than in the children (p < 0.001; 
Table 2).
muscle strength. All tests and measurements 
were performed by the same researcher. The 
individuals evaluated were previously instructed 
to wear light clothing and not to eat 30 min 
before the tests. They were also instructed to 
avoid vigorous physical activity and not to drink 
alcoholic beverages, coffee, or soft drinks in the 
24 h preceding the tests.
Spirometry was performed with an EasyOne-
2010® spirometer (NDD Medizintechnik AG, 
Munich, Germany), which was calibrated daily 
in accordance with the recommendations of one 
study.(23) The test was performed in accordance 
with the aforementioned recommendations,(23) and 
FVC, FEV1, FEV1/FVC, and PEF were measured. 
The values obtained are expressed as percentage 
of predicted normal for gender and height.(23)
Albuterol (400 µg/dose) was used only for 
the asthma group, and spirometry was repeated 
15 min later. A positive bronchodilator response 
was defined as an increase ≥ 200 mL or of 12% 
in FEV1 or FVC in relation to the baseline values, 
or a 7% increase in FEV1 or FVC in relation to 
the predicted values. This constituted a criterion 
to confirm the diagnosis of asthma.
An analog manometer (Gerar, São Paulo, Brazil) 
with an operating range of ± 300 cmH2O was used 
to measure MIP and MEP. In accordance with the 
recommendations of two studies,(25,26) MEP was 
measured at TLC (maximal inspiratory maneuver) 
and MIP was measured at RV (maximal expiratory 
maneuver). The maneuvers were performed five 
to eight times or until the last measured value 
was lower than the second from last. The values 
should have a maximum variation of 10%, three 
reproducible curves being required. The highest 
pressure peaks were recorded, provided that they 
lasted at least 1 s.
A rigid plastic mouthpiece with an air outlet of 
2 mm in diameter distal to the patient was used 
in order to avoid the influence of the pressures 
generated by the facial muscles. In addition, 
the participants were instructed to press their 
cheeks with their hands during MEP measurement. 
The accuracy of MIP and MEP measurements 
was ± 5 cmH2O. All measurements were performed 
with the patients in a sitting position.
A 15% difference in inspiratory muscle strength 
was considered to be a clinically significant value, 
and the sample size was calculated considering 
this difference in MIP between the two groups, 
with a power of 80% and a level of significance of 
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patients had airflow obstruction, as evidenced 
by a significant reduction in FEV1, they showed 
no impairment of respiratory muscle strength, 
a finding that is consistent with those of other 
studies.(29,30)
Asthma patients with mild or moderate 
obstructive pulmonary disease might not have 
significant lung hyperinflation resulting in changes 
in diaphragm position. Lung hyperinflation 
increases functional residual capacity, and this 
leads to changes in respiratory mechanics and 
flattening of the diaphragm. The flattening 
of the diaphragm constitutes a mechanical 
disadvantage, which can be inferred by the 
reduction in respiratory muscle strength. The 
patients evaluated in the present study had mild 
or moderate airway obstruction, which probably 
explains the similarity in MIP and MEP between 
the asthma patients and the healthy subjects.
Among the patients with asthma, MEP was 
significantly lower in the children than in the 
adolescents, which was expected because of the 
physiological growth. Wagener et al.(16) found that 
respiratory muscle strength was higher in post-
There were no significant differences between 
the children with asthma and the control children 
regarding MIP (p = 0.117) or MEP (p = 0.961). 
There were no significant differences in MIP 
or MEP between the adolescents with asthma 
and the control adolescents (p = 0.257 and 
p = 0.291, respectively).
There were no significant correlations of FEV1, 
FVC, or FEV1/FVC with MIP or MEP (p > 0.05; 
r < 0.2 for all).
Discussion
Maximal respiratory pressures reflect respiratory 
muscle strength. Measurement of these pressures 
is a simple, reproducible, and noninvasive test that 
is easy to understand and allows the determination 
of respiratory muscle weakness and the monitoring 
of patients with chronic lung disease.(27,28)
We found no differences in respiratory muscle 
strength (MIP and MEP) between children with 
asthma and age- and gender-matched controls or 
between adolescents with asthma and age- and 
gender-matched controls. Although the asthma 
Figure 2 - Error bar chart of maximal respiratory pressures in the groups studied. In A, MIP. In B, MEP.
Table 1 - Characteristics of the population studied.a 
Characteristic Asthma group Control group p*
(n = 75) (n = 90)
Age, years 10.0 ± 2.6 10.0 ± 2.7 0.927
FEV1, % of predicted 76.4 ± 17.5 95.5 ± 10.3 0.001
FVC, % of predicted 96.1 ± 18.6 96.8 ± 17.9 0.852
FEV1/FVC, % 70.4 ± 18.6 85.4 ± 5.7 < 0.001
PEF, mL/s 66.6 ± 19.1 92.4 ± 16.5 0.036
aValues expressed as mean ± SD. *Student’s t-test.
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muscle strength or efficiency. Therefore, although 
lung hyperinflation can lead to changes in MIP, 
age has no direct influence on MIP.
Our finding that MIP was similar between the 
children and adolescents in the asthma group 
but not between those in the control group 
allows us to infer that the pulmonary function 
impairment caused by the disease can prematurely 
affect respiratory muscle strength in children, 
making it similar to that of adolescents. This 
finding has been reported by other authors(10-12) 
as being a type of involuntary muscle training 
caused by airway closure leading to changes in 
MIP in individuals with obstructive pulmonary 
disease. Children with increased MIP will not 
present with impaired respiratory mechanics at 
this point, because the respiratory system is still 
developing and can adapt. However, knowing 
that this is probably due to airway obstruction 
and that asthma chronicity is associated with the 
completion of respiratory system development, 
flattening of the diaphragm resulting from 
hyperinflation can produce greater or lesser 
impairment of MIP.
Assuming that airway obstruction would cause 
an increase in MIP, we expected that maximal 
respiratory pressures in patients with asthma 
would correlate with spirometric variables, as 
described in previous studies.(15,18,30) However, in 
our study, neither MIP nor MEP correlated with 
FEV1, FVC, or FEV1/FVC in the asthma group. 
This finding is inconsistent with the literature 
and can be explained by the degree of airway 
obstruction in the group of patients under study. 
The patients evaluated in the present study had 
mild or moderate obstruction, which probably 
contributed to the lack of significant correlation 
between spirometry results and respiratory muscle 
strength. Although we found no significant 
correlations, we found changes in MIP, meaning 
that the degree of obstruction was probably 
sufficient to cause an early increase in MIP in 
the children with asthma.
pubertal individuals and that MEP was lower in 
children than in adolescents or adults, a finding 
that is consistent with those of the present study. 
Those results were explained by the greater muscle 
area in the older individuals. We believe that 
growth and pubertal stage influence respiratory 
muscle strength, as they are known to influence 
upper and lower body muscle strength. We did 
not assess the pubertal stage of the participants; 
the groups were subdivided exclusively on the 
basis of chronological age, which prevents us 
from drawing definitive conclusions regarding 
this issue, although changes in respiratory muscle 
strength have been reported to correlate with 
age.(27)
In the asthma group, MIP was similar between 
the children and adolescents. Having in mind 
muscle growth and development, we expected 
that inspiratory muscle strength would behave 
similarly to expiratory muscle strength, i.e., greater 
age would translate to higher values. However, 
this proved not to be the case.
Growth-related variations in MIP have been 
described by various authors.(16,17,25) However, 
Galtier et al. found that MIP only partially reflected 
the development of respiratory muscle strength, 
given that respiratory muscle strength is the 
product of pressure and surface area over which 
pressure is applied and that both increase with 
growth.(25) Those authors measured maximal 
respiratory pressures in healthy children aged 
8-11 years and correlated the pressures with lung 
volumes and chest wall diameters. They concluded 
that, as in adults, MIP in children varies with lung 
volumes, being directly related to VC and increasing 
with age, even before puberty; therefore, greater 
age and higher VC translate to higher MIP.(25) 
On the basis of the same principle, Weiner et al.
(29) assessed the effects of lung hyperinflation 
on respiratory muscle function in patients with 
asthma. Those authors found that only male 
patients with asthma had reduced respiratory 
muscle strength and efficiency, there being no 
correlation between age and reduced respiratory 
Table 2 - MIP and MEP in the groups and subgroups studied.a,b 
Pressure Asthma group p* Control group p*
Children Adolescents Children Adolescents
MIP, cmH2O −87.5 ± 26.0 −94.5 ± 26.4 0.285 −79.1 ± 17.7 −100.9 ± 28.1 < 0.001
MEP, cmH2O 74.1 ± 24.1 92.1 ± 21.9 < 0.001 73.9 ± 18.7 90.9 ± 28.1 < 0.001
aValues expressed as mean ± SD. bChildren: 6-12 years of age; adolescents: 13-16 years of age. *Student’s t-test.
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J Pediatr (Rio J). 2000;76 Suppl 3:S275-84. http://
dx.doi.org/10.2223/JPED.164
25. Gaultier C, Zinman R. Maximal static pressures in healthy 
children. Respir Physiol. 1983;51(1):45-61. http://dx.doi.
org/10.1016/0034-5687(83)90101-9
26. Neder JA, Andreoni S, Lerario MC, Nery LE. Reference 
values for lung function tests. II. Maximal respiratory 
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The results of the present study cannot be 
generalized to patients with severe asthma, 
because such patients were not included in 
the study protocol. We believe that there is a 
need for specific studies of patients with severe 
asthma, and we can infer that there are changes 
in respiratory muscle strength in this group of 
patients. However, a study protocol including 
a specific methodology should be developed to 
address this issue.
In conclusion, mild or moderate persistent 
asthma was found to have no significant effect 
on respiratory muscle strength. In the control 
group, MIP and MEP were found to be lower in 
the children than in the adolescents, whereas, in 
the asthma group, MIP was similar between the 
children and adolescents, meaning that MIP was 
prematurely increased in the children. There were 
no significant correlations between spirometric 
variables and maximal respiratory pressures.
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